SHANK3 and autism spectrum disorder: Nitric oxide inhibition ameliorates cortical proteomic changes in the Cntnap2&lt;sup&gt;-/-&lt;/sup&gt; and Shank3&lt;sup&gt;Δ4-22&lt;/sup&gt; mouse models of autism spectrum disorder.